I believe they do have the data. Based on this ol
Post# of 72436
"Cellceutix will not know the actual cure rates per treatment arm until the data is unblinded in October/November. However, the Company is very optimistic and views the high average cure rate on the blinded data as a very good sign for Brilacidin. Assuming positive results after unblinding, Cellceutix will have proven that Brilacidin is a safe and effective drug in the Phase 2 trial, and all activities will be triggered for initiation of a pivotal Phase 3 trial."
http://cellceutix.com/cellceutix-provides-ini...Sh7Ex.dpbs
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)